Celldex Therapeutics buy Wells Fargo & Company
Start price
13.05.26
/
50%
€27.84
Target price
13.05.27
€46.01
Performance (%)
19.83%
Price
31.07.26
€32.95
Summary
This prediction is currently active. The prediction currently has a performance of 19.83%. This prediction currently runs until 13.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 7.399% | 7.399% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Wells Fargo & Company from $38.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€32.68
29.07.26
29.07.26
€63.18
29.07.27
29.07.27
1.81%
31.07.26
31.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€42.08
22.07.27
22.07.27
9.48%
31.07.26
31.07.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
81.30%
31.07.26
31.07.26